Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
836.00    14.00 (1.70%)
Bid:
826.00
Ask:
836.00
Spread: 10.00 (1.211%)
Market Cap: £385.36m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

AGM Trading Update

14 Apr 2026 07:00

RNS Number : 2840A
Porvair PLC
14 April 2026
 

14 April 2026

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

AGM Trading Update

Group trading remains in line with our full year expectations. Integration of Drache acquisition remains on track.

Porvair plc ("Porvair" or the "Group"), the specialist filtration, laboratory and environmental technology group, will make the following trading statement at its Annual General Meeting to be held at 11.00 am today:

Four-month trading summary for the period to 31 March 2026

The Group has performed in line with expectations in the first four months of the year, delivering constant currency revenue growth of 5%. This performance reflects the qualities of Porvair's diversified portfolio, as market conditions remain varied across the Group's end markets.

Aerospace & Industrial

Aerospace order books remain strong, noting that the timing of delivery can be affected by changes in customer scheduling. Robust nuclear demand in the second half of 2025 has continued into the current year. Petrochemical sales, which can be lumpy, are lower compared with a strong prior period, and conditions in the European petrochemical market are expected to remain subdued throughout 2026.

Laboratory

Within life sciences, consumables order patterns remain steady, while environmental demand for instruments is in line with the prior year. New product introductions across life sciences and environmental are progressing as planned.

Metal Melt Quality

Aluminium and superalloys demand remains firm, whilst the auto, truck and agriculture end-markets, which represent a smaller part of the Group, remain subdued. There has been good progress with the new £5.5m aluminium cast house manufacturing line in Hendersonville, US, which remains on track for commissioning in the first half of 2026. The integration of Drache, acquired on 12 January 2026, is progressing well after three months with the Group and trading is consistent with the pre-acquisition investment case.

Outlook

The Board is closely monitoring the situation in the Middle East, in terms of both macro uncertainty and rising input prices. The Group's manufacturing footprint mainly serves local customers, and its decentralised management structure provides flexibility, agility and resilience in navigating volatile trading conditions, enabling key commercial decisions to be made closer to customers and suppliers.

The Board's expectations of the Group's full year performance remain unchanged, supported by a diversified customer base, strong recurring revenue streams and disciplined operational management. An increased focus on identifying M&A targets has surfaced some interesting prospects which are currently being evaluated. The Board sees no change in the Group's long-term strategic outlook or global growth drivers.

Capital Markets Event

Further to the full year results announcement, Porvair will host a Capital Markets Event in London on Thursday, 15 October 2026. Further details will be provided in due course.

Notice of results

The Group will announce its interim results for the six months ending 31 May 2026 on Monday 29 June 2026.

 

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Hooman Caman Javvi, Chief Executive Officer

James Mills, Group Finance Director

 

Alma Strategic Communications

+44 (0)20 3405 0205

Andrew Jaques / Josh Royston / Hannah Campbell / Rose Docherty

 

 

LEI: 213800ECKHS8LAQO3C45

 

Notes to editors

Porvair is a group of specialist filtration, laboratory and environmental technology companies. Our businesses design and manufacture bespoke consumable filtration products that are used in a range of niche markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMEAFLDFASKEAA
Date   Source Headline
12th Apr 20162:51 pmRNSAGM resolutions
18th Mar 201612:45 pmRNSHolding(s) in Company
7th Mar 20169:01 amRNSHolding(s) in Company
7th Mar 20169:00 amRNSHolding(s) in Company
1st Feb 201611:38 amRNSDirector/PDMR Shareholding
25th Jan 20167:00 amRNSFull Year Results
7th Dec 20157:00 amRNSPre-close trading update and acquisition
17th Sep 20154:15 pmRNSDirector/PDMR Shareholding
15th Sep 20157:00 amRNSTrading Update
12th Aug 20151:15 pmRNSHolding(s) in Company
12th Aug 20151:11 pmRNSHolding(s) in Company
10th Jul 201512:45 pmRNSDirector/PDMR Shareholding
29th Jun 20157:00 amRNSInterim Results
23rd Jun 20155:00 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSTrading Update
29th May 20155:31 pmRNSTotal Voting Rights
30th Apr 20157:02 amRNSDirector declaration
14th Apr 20152:55 pmRNSAGM resolutions
14th Apr 20157:00 amRNSAGM Statement and Trading Update
24th Mar 20152:25 pmRNSPosting of Accounts
11th Mar 20157:00 amRNSHolding(s) in Company
5th Feb 20157:00 amRNSHolding(s) in Company
30th Jan 20154:03 pmRNSEx-Dividend Date
27th Jan 201512:11 pmRNSDirectors' Shareholdings and Issue of Equity
26th Jan 201512:30 pmRNSDirector Declaration
26th Jan 20157:00 amRNSSignificant Contract Wins
26th Jan 20157:00 amRNSFull Year Results
4th Dec 20147:00 amRNSSignificant Contract Win
1st Dec 20147:00 amRNSPre-close trading update
5th Nov 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:00 amRNSInterim Management Statement
23rd Jun 20147:00 amRNSInterim Results
5th Jun 20148:50 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTrading Update
23rd Apr 201411:39 amRNSDirector Declaration
8th Apr 20144:20 pmRNSAGM resolutions
8th Apr 20147:00 amRNSAGM Statement and IMS
25th Feb 20147:00 amRNSAppointment of Non-Executive Director
3rd Feb 201410:08 amRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSPreliminary Results
16th Jan 20144:07 pmRNSBlocklisting Application
4th Dec 20137:00 amRNSPre-close trading update
29th Nov 20134:02 pmRNSTotal Voting Rights
26th Sep 20137:00 amRNSAcquisition and Licensing agreement
25th Sep 20134:10 pmRNSDirector/PDMR Shareholding
17th Sep 20137:00 amRNSInterim Management Statement
7th Aug 20134:32 pmRNSHolding(s) in Company
6th Aug 20137:00 amRNSContract extension
15th Jul 201311:17 amRNSHolding(s) in Company
9th Jul 20135:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.